We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
Cap. Flow
+$47.8M
Cap. Flow %
7.17%
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644

Top Buys

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$3.83M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$3M
3
TECK icon
Teck Resources
TECK
+$2.87M
4
MODV
ModivCare
MODV
+$2.67M
5
G icon
Genpact
G
+$2.6M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.07M
2
CHS
Chicos FAS, Inc.
CHS
+$2.68M
3
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$2.45M
4
CXT icon
Crane NXT
CXT
+$2.44M
5
ATCO
Atlas Corp.
ATCO
+$2.27M

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 15.11%
3 Consumer Discretionary 12.76%
4 Industrials 12.53%
5 Financials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RBA icon
376
RB Global
RBA
$17.6B
$610K 0.09%
+9,369
New +$550K
SAGE
377
DELISTED
Sage Therapeutics
SAGE
$606K 0.09%
+18,750
New +$628K
BFH icon
378
Bread Financial
BFH
$4.4B
$605K 0.09%
+16,333
New +$832K
DRH icon
379
Diamondrock Hospitality Co
DRH
$2.57B
$603K 0.09%
+73,456
New +$716K
VBTX
380
DELISTED
Veritex Holdings
VBTX
$603K 0.09%
20,598
-5,503
-21% -$183K
IART icon
381
Integra LifeSciences
IART
$1.33B
$602K 0.09%
+11,151
New +$670K
MKTX icon
382
MarketAxess Holdings
MKTX
$5.72B
$600K 0.09%
2,342
-373
-14% -$102K
PAHC icon
383
Phibro Animal Health
PAHC
$1.41B
$600K 0.09%
31,383
-7,978
-20% -$151K
ORA icon
384
Ormat Technologies
ORA
$6.7B
$599K 0.09%
7,641
-18,803
-71% -$1.48M
CTAS icon
385
Cintas
CTAS
$81.3B
$598K 0.09%
6,400
+3,368
+111% +$328K
MMI icon
386
Marcus & Millichap
MMI
$1.2B
$595K 0.09%
16,077
+12,135
+308% +$528K
CVS icon
387
CVS Health
CVS
$122B
$594K 0.09%
6,415
-1,156
-15% -$113K
SNX icon
388
TD Synnex
SNX
$20.4B
$594K 0.09%
6,521
-14,578
-69% -$1.45M
RVNC
389
DELISTED
Revance Therapeutics, Inc.
RVNC
$594K 0.09%
42,978
-24,254
-36% -$373K
ADT icon
390
ADT
ADT
$5.58B
$592K 0.09%
96,205
+50,065
+109% +$349K
IDEX
391
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$591K 0.09%
7,137
+472
+7% +$42.5K
AVA icon
392
Avista
AVA
$3.27B
$589K 0.09%
+13,541
New +$582K
KYMR icon
393
Kymera Therapeutics
KYMR
$8.86B
$589K 0.09%
29,922
+23,920
+399% +$559K
BIG
394
DELISTED
Big Lots, Inc.
BIG
$589K 0.09%
+28,087
New +$826K
NVCR icon
395
NovoCure
NVCR
$1.88B
$588K 0.09%
+8,462
New +$637K
TMX
396
DELISTED
Terminix Global Holdings, Inc.
TMX
$588K 0.09%
14,477
-50,938
-78% -$2.21M
DE icon
397
Deere & Co
DE
$169B
$585K 0.09%
1,952
+129
+7% +$47.5K
MYE icon
398
Myers Industries
MYE
$1.32B
$585K 0.09%
25,746
+13,898
+117% +$315K
PLRX icon
399
Pliant Therapeutics
PLRX
$64.4M
$585K 0.09%
73,053
+4,817
+7% +$30.8K
ANNX icon
400
Annexon
ANNX
$888M
$584K 0.09%
154,920
+115,276
+291% +$352K
14 15
16
17 18

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.

  • GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
  • GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
  • GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
  • GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
  • GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
  • GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.